Cumulative prostate cancer risk assessed in 173 BCLC-BRCA2 families was 7.5% (95% CI 5.7–9.3%) by age 70 years, corresponding to a RR of 4.65 (95% CI 3.48–6.22), which may include a detection bias. The gene discussed is BRCA2; the disease is prostate carcinoma.